1. Home
  2. TFII vs CYTK Comparison

TFII vs CYTK Comparison

Compare TFII & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TFI International Inc.

TFII

TFI International Inc.

HOLD

Current Price

$115.44

Market Cap

9.2B

Sector

Industrials

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$65.04

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFII
CYTK
Founded
1957
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
TFII
CYTK
Price
$115.44
$65.04
Analyst Decision
Buy
Strong Buy
Analyst Count
11
17
Target Price
$121.09
$85.24
AVG Volume (30 Days)
411.8K
1.6M
Earning Date
02-17-2026
02-27-2026
Dividend Yield
1.45%
N/A
EPS Growth
N/A
N/A
EPS
3.89
N/A
Revenue
$8,047,566,000.00
$87,211,000.00
Revenue This Year
N/A
$341.94
Revenue Next Year
$2.77
$50.15
P/E Ratio
$32.29
N/A
Revenue Growth
N/A
2609.26
52 Week Low
$72.02
$29.31
52 Week High
$131.33
$70.98

Technical Indicators

Market Signals
Indicator
TFII
CYTK
Relative Strength Index (RSI) 51.97 52.62
Support Level $118.46 $60.05
Resistance Level $122.88 $67.10
Average True Range (ATR) 4.42 2.71
MACD 0.39 0.15
Stochastic Oscillator 41.95 62.03

Price Performance

Historical Comparison
TFII
CYTK

About TFII TFI International Inc.

TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customers' specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: